Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Rapid worsening of IgM anti-MAG demyelinating polyneuropathy during rituximab treatment.
Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists.
Immunoregulatory Effects of Interferon-β in Suppression of Th17 cells.
Diffusion tensor MRI alterations of subcortical deep gray matter in clinically isolated syndrome.
Immune Rebound: Multiple Sclerosis after Treatment of Cushing's Disease.
Progressive multifocal leukoencephalopathy in an immunocompetent patient.
Multiple sclerosis: Vitamin D deficiency leads to excessive B-cell responses in multiple sclerosis.
Graphene Functionalized Scaffolds Reduce the Inflammatory Response and Supports Endogenous Neuroblast Migration when Implanted in the Adult Brain.
Highlights from this issue.
Sleep Disorders in Multiple Sclerosis.
Acute disseminated encephalomyelitis and other inflammatory demyelinating variants.
SOX2+ Cell Population from Normal Human Brain White Matter Is Able to Generate Mature Oligodendrocytes.
[Effective rehabilitation of hospitalized patients with multiple sclerosis].
Increased cerebrospinal fluid osteopontin levels and its involvement in macrophage infiltration in neuromyelitis optica.
Perspectives on neuroreparative therapies for treating multiple sclerosis.
A competitive advantage by neonatally engrafted human glial progenitors yields mice whose brains are chimeric for human glia.
Anti-MS4a4B treatment abrogates MS4a4B-mediated protection in T cells and ameliorates experimental autoimmune encephalomyelitis.
Temporal and spatial evolution of grey matter atrophy in primary progressive multiple sclerosis.
[Teriflunomide for treatment of multiple sclerosis.]
Early magnetic resonance detection of natalizumab-related progressive multifocal leukoencephalopathy in a patient with multiple sclerosis.
Neuromyelitis optica.
Optimal attenuation of experimental autoimmune encephalomyelitis by intravenous immunoglobulin requires an intact interleukin-11 receptor.
Mesenchymal cells of umbilical cord and umbilical cord blood as a source of human oligodendrocyte progenitors.
Neocortical Neuronal Loss in Patients with Multiple System Atrophy: A Stereological Study.
Small heat shock proteins are induced during multiple sclerosis lesion development in white but not grey matter.
Pages
« first
‹ previous
…
668
669
670
671
672
673
674
675
676
…
next ›
last »